Extending and validating the Baveno VI criteria for the exclusion of high-risk varices

Andreea Barbulescu1, Iulia Ratiu2, Ioan Sporea3

  • 1Department of Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania. barbulescu.andra91@gmail.com.

Insights

The Baveno VI guidelines accurately exclude high-risk varices (HRV) in cirrhotic patients. Adding albumin thresholds improves accuracy, potentially eliminating unnecessary esophago-gastro-duodenoscopy (EGD) screenings.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Diagnostic Accuracy

Background:

  • Compensated advanced chronic liver disease (cACLD) management guidelines recommend screening for high-risk varices (HRV).
  • Esophago-gastro-duodenoscopy (EGD) is the standard for HRV screening but is invasive.
  • The Baveno VI guidelines suggest avoiding EGD in cACLD patients with liver stiffness (LSM) <20 kPa and platelet count (PLT) >150,000/L.

Purpose of the Study:

  • To validate the extended Baveno VI criteria in a large cohort of patients with chronic liver disease.
  • To establish specific cut-off values for liver stiffness and platelet count for HRV screening in the study population.
  • To assess the utility of albumin levels in refining HRV risk stratification.

Main Methods:

  • Retrospective analysis of 839 patients with liver cirrhosis.
  • Evaluation using Transient Elastography (TE), laboratory tests, and upper endoscopy within one year.
  • Validation of Baveno VI criteria on a randomly selected cohort (Cohort 1, n=728) and determination of tailored cut-offs, with validation on a separate cohort (Cohort 2, n=111).

Main Results:

  • Baveno VI criteria demonstrated 86.2% accuracy in Cohort 1.
  • Tailored cut-offs for ruling out HRV were PLT >150,000/mm³ and LSM <19.6 kPa.
  • Albumin <3.4 g/dL was independently associated with HRV in the grey-zone. The rule-out criteria achieved 100% accuracy in Cohort 2.

Conclusions:

  • The Baveno VI criteria show good accuracy for excluding HRV in cirrhotic patients.
  • Incorporating an albumin threshold enhances the performance and applicability of HRV screening criteria.
  • Utilizing the derived rule-out criteria can effectively prevent unnecessary EGD procedures.
Abstract

Related Concept Videos

Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
69
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
230
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
664
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
118
Varicose Veins I: Introduction01:26

Varicose Veins I: Introduction

Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
72
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
92